Healthequity (HQY) Receives a Buy from BTIG
September 07 2022 - 12:45AM
TipRanks
In a report released yesterday, David Larsen from BTIG maintained a
Buy rating on Healthequity (HQY - Research Report), with a price
target of $85.00. The company's shares closed yesterday at
$63.44.According to TipRanks, Larsen is an analyst with an average
return of -8.5% and a 34.76% success rate. Larsen covers the
Technology sector, focusing on stocks such as Omnicell, Health
Catalyst, and Sharecare.Healthequity has an analyst consensus of
Moderate Buy, with a price target consensus of $75.00, a 18.22%
upside from current levels. In a report released on September 2,
Barrington also reiterated a Buy rating on the stock with a $75.00
price target.
https://www.tipranks.com/news/blurbs/healthequity-hqy-receives-a-buy-from-btig?utm_source=advfn.com&utm_medium=referral
HealthEquity (NASDAQ:HQY)
Historical Stock Chart
From Jan 2023 to Feb 2023
HealthEquity (NASDAQ:HQY)
Historical Stock Chart
From Feb 2022 to Feb 2023